Evidence map›Paper›PMID 32938777›Full record

ArticlePediatrics2020

Pathogenic Yield of Genetic Testing in Autism Spectrum Disorder.

Holly K Harris, Georgios D Sideridis, William J Barbaresi, Elizabeth Harstad

Open access · bronzeAbstract read
In one paragraph

Article in Pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Practitioner Review: Psychosis in children and adolescents.Journal of child psychology and psychiatry, and allied disciplines · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Holly K HarrisDivision of Developmental Medicine, Boston Children's Hospital and Harvard Medical School, Harvard University, Boston, Massachusetts; and.
Georgios D SideridisDivision of Developmental Medicine, Boston Children's Hospital and Harvard Medical School, Harvard University, Boston, Massachusetts; and.
William J BarbaresiDivision of Developmental Medicine, Boston Children's Hospital and Harvard Medical School, Harvard University, Boston, Massachusetts; and.
Elizabeth HarstadDivision of Developmental Medicine, Boston Children's Hospital and Harvard Medical School, Harvard University, Boston, Massachusetts; and elizabeth.harstad@childrens.harvard.edu.
Harvard University · USBoston Children's Hospital · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
NCRR NIH HHS UL1 RR025780
6 · The paper itself

Abstract

BACKGROUND AND

objectivesGenetic testing is recommended for individuals with autism spectrum disorder (ASD). Pathogenic yield varies by clinician and/or patient characteristics. Our objectives were to determine the pathogenic yield of genetic testing, the variability in rate of pathogenic results based on subject characteristics, and the percentage of pathogenic findings resulting in further medical recommendations in toddlers with a

methodsWe conducted a retrospective chart review of 500 toddlers, 18 to 36 months, diagnosed with

resultsOver half of subjects (59.8%,

conclusionsOur findings reinforce the importance of genetic testing for toddlers diagnosed with ASD given the 12% yield and lack of phenotypic differences between subjects with and without pathogenic findings. The majority of pathogenic results lead to further medical recommendations.

Indexed as

Autism Spectrum DisorderBody Dysmorphic DisordersChild, PreschoolChromosomes, Human, 13-15CognitionDiagnostic and Statistical Manual of Mental DisordersFemaleFragile X Messenger Ribonucleoprotein 1Gene DeletionGene DuplicationGenetic TestingHumansInfantLanguage DevelopmentMaleMicroarray AnalysisFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

PMID32938777
PMCPMC7786819
OpenAlexW3085780485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.